Viridian Therapeutics
Price & Volume
Stats
See more52W Range | $11.40-$25.38 |
Market Cap | $1.7B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $288,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$99.1M |
Diluted EPS | -$4.25 |
News
See moreYahoo Finance • last year
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
Yahoo Finance • last year
Viridian Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Yahoo Finance • 2 years ago
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 years ago
Viridian Therapeutics to Webcast First Quarter 2023 Financial Results and Corporate Update on May 9, 2023
About
CEO | Mr. Stephen F. Mahoney J.D., MBA |
Address | 221 Crescent Street, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 94 |
